In the News

Second-line therapies for type 2 diabetes may offer similar glycemic control

The only significant difference found by the meta-analysis was a small increase in myocardial infarction and eye disorders with sulfonylureas compared with dipeptidyl peptidase-4 inhibitors.

Intensive glucose control soon after diagnosis may improve diabetes outcomes, study indicates

The findings underscore the urgency of early diagnosis of diabetes and the consequences of failing to achieve near-normal glycemia soon after patients are diagnosed, according to the study authors.

Diabetes patients without other risk factors may have near-normal mortality risks

The studied risk factors were HbA1c level, LDL cholesterol level, presence of albuminuria, smoking status, and blood pressure.

MKSAP quiz: STEMI, heart failure, and diabetes

This month's quiz asks readers to evaluate a 66-year-old man in the hospital following an ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention.

Spotlight on heart failure

Two studies compared heart failure rates in patients with and without type 2 diabetes, while a third looked at the risk of heart failure associated with various classes of glucose-lowering drugs.

Recent WHO diabetes guideline summarized and critiqued

The updated guideline from the World Health Organization (WHO) included five recommendations, some of which differed from ACP's most recent diabetes guideline.

National Institutes of Health provides updated diabetes guide

The third edition of “Diabetes in America” is free and covers diabetes epidemiology, prevention, care, and complications.

Warning about serious genital infections in patients taking SGLT2 inhibitors

The FDA has identified 12 cases of necrotizing fasciitis of the perineum or Fournier's gangrene. All 12 patients were hospitalized and required surgery, and one died.